Genesco (GCO) EPS (Weighted Average and Diluted) (2016 - 2026)
Genesco has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $4.55 for Q1 2026.
- Quarterly results put EPS (Weighted Average and Diluted) at $4.55 for Q1 2026, up 43.99% from a year ago — trailing twelve months through Jan 2026 was $1.25 (up 171.84% YoY), and the annual figure for FY2026 was $1.25, up 171.84%.
- EPS (Weighted Average and Diluted) for Q1 2026 was $4.55 at Genesco, up from $0.51 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for GCO hit a ceiling of $4.55 in Q1 2026 and a floor of -$2.79 in Q3 2023.
- Median EPS (Weighted Average and Diluted) over the past 5 years was $0.51 (2025), compared with a mean of $0.48.
- Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 572.88% in 2023 and later soared 128.98% in 2025.
- Genesco's EPS (Weighted Average and Diluted) stood at $1.66 in 2022, then crashed by 63.86% to $0.6 in 2023, then crashed by 393.33% to -$1.76 in 2024, then surged by 128.98% to $0.51 in 2025, then skyrocketed by 792.16% to $4.55 in 2026.
- The last three reported values for EPS (Weighted Average and Diluted) were $4.55 (Q1 2026), $0.51 (Q4 2025), and -$1.79 (Q3 2025) per Business Quant data.